Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer’s disease

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2010) Michael Gold et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment

(2010) A. M. Abbatecola et al.   DIABETES CARE

Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents

(2010) R.K. Kaundal et al.   DRUG NEWS & PERSPECTIVES

The nuclear receptor PPARγ as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer's disease

(2010) Nektaria Nicolakakis   Frontiers in Aging Neuroscience

PPARγ transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons

(2009) Jing Du et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease

(2009) Qingguang Jiang et al.   CNS DRUGS

Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice

(2009) Wei-Zu Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Alzheimer's disease mitochondrial cascade hypothesis: An update

(2009) Russell H. Swerdlow et al.   EXPERIMENTAL NEUROLOGY

Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia

(2009) Baljinder Kaur et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Distinct modulation of voltage-gated and ligand-gated Ca2+currents by PPAR-γ agonists in cultured hippocampal neurons

(2009) Tristano Pancani et al.   JOURNAL OF NEUROCHEMISTRY

PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS

(2009) Haruo Hanyu et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome

(2009) Tom Hsun-Wei Huang et al.   PHARMACOLOGICAL RESEARCH

Molecular mechanism of PPAR in the regulation of age-related inflammation

(2008) Jae Heun Chung et al.   AGEING RESEARCH REVIEWS

Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?

(2008) Michelangelo Mancuso et al.   Current Alzheimer Research

Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats

(2008) Asif R. Pathan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

ApoE Promotes the Proteolytic Degradation of Aβ

(2008) Qingguang Jiang et al.   NEURON

PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease

(2008) Gary Landreth et al.   Neurotherapeutics

Fibrates and future PPARα agonists in the treatment of cardiovascular disease

(2008) Bart Staels et al.   Nature clinical practice. Cardiovascular medicine

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

(2007) Huaqi Xiong et al.   NEUROBIOLOGY OF DISEASE

Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats

(2007) Randy L. Hunter et al.   NEUROSCIENCE LETTERS